Patent Issued for Purinones as ubiquitin-specific protease 1 inhibitors (USPTO 12043623).

Předmět:	DNA repair PROLIFERATING cell nuclear antigen DEUBIQUITINATING enzymes SMALL molecules HOMOLOGOUS recombination
Zdroj:	Pharma Business Week; 8/16/2024, p1904-1904, 1p
Abstrakt:	A patent has been issued for purinones as ubiquitin-specific protease 1 (USP1) inhibitors. USP1 is a deubiquitinating enzyme that plays a role in regulating cellular processes and is often deregulated in cancers. Inhibition of USP1 with small molecule inhibitors has the potential to be a treatment for cancers and other disorders. The patent, assigned to Forma Therapeutics Inc., provides information on compounds and formulas related to the inhibitors. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu